Assessment of Safety and Efficacy of Tofacitinib, Stratified by Age, in Patients from the Ulcerative Colitis Clinical Program.

Gary R LichtensteinBrian BresslerCarlos FrancisconiSeverine VermeireNervin LawendyLeonardo SaleseGosford SawyerrHongjiong ShiChinyu SuDonna T JuddThomas JonesEdward V Loftus

Published in: Inflammatory bowel diseases (2022)

NCT00787202; NCT01465763; NCT01458951; NCT01458574; NCT01470612.

Keyphrases

ulcerative colitis
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
rheumatoid arthritis
prognostic factors
patient reported outcomes